“Real-World Treatment Outcomes and Safety Profiles of Tyrosine Kinase Inhibitors in Iraqi Patients with Chronic Myeloid Leukemia”, mfm, vol. 36, no. 8, Sep. 2025, doi: 10.60110/medforum.360807.